Navigation Links
Quick and Inexpensive DNA Testing

Professor Lewis Rothberg of the University of Rochester was awarded a NYSTAR grant to resume his research on a recent discovery by one of his team members//. He along with his colleagues contributed to a remarkable research. They developed cost effective methods to study DNA material in quick simple steps. This will ensure better health and clean drinking water and make sure that we eat uncontaminated food. Rothberg's novel method can even be used in several other applications like assisting forensic experts to pinpoint criminals, and in earmarking potentially dangerous genetic sequences in medical research field. Rothberg's ground breaking research paves the way to identify sequences in genotypes in any DNA sample rapidly and cost effectively.

The technology is a novel fluorescent DNA screening assay, which rapidly determines whether specific DNA target sequences are present in an analyte. In simple terms, the analyte contains the DNA target sequences as well as other DNA sequences, and the assay filters out only the targets. Professor Rothberg's assay is based on the electrostatic properties of DNA.

The principle underlying the method is that single-stranded DNA and double-stranded DNA have significantly different affinities for attaching to ionically charged gold nanoparticles. Because ions have electric charges, having gained or lost electrons, they attract their opposites. An anion with a negative electric charge will attract positive charges, a cation with a positive charge will attract negative charges. Single-stranded DNA adsorbs on negatively charged citrate ions on the gold nanoparticles while double-stranded DNA does not. Given that both single-stranded and double-stranded DNA are (nominally) negatively charged, this proven phenomenon intrigues the research group.

The new assay determines whether a fluorescently-tagged short probe sequence of single-stranded DNA matches a sequence in the target analyte. When it does not,
'"/>




Page: 1 2

Related medicine news :

1. Prototype Detector detects Anthrax Quickly
2. Quicker healing with active bandages
3. Energy Therapy For Quicker Healing
4. Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki
5. Health Officials Inquire Into OraQuick HIV Tests
6. Quick Recovery in Rodeo Athletes
7. Child Diarrhoea Due To Rotavirus:Quick Relief By Short Course Drug
8. Depression Could Quickly Grow Into UK’s Biggest Proble
9. Quick freezing technique of the human egg
10. Google-Like Model Used To Diagnose Suspicious Breast Masses Quickly
11. Stress Could Have A Notable Effect In Quickening The Progression Of Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Quick and Inexpensive DNA Testing

(Date:7/18/2008)...state-of-the-art radiation technology ...ER, Texas, July 18 /PRNewswire/ -- Patients of Tri...as Oncology-Tyler are among the first,in the natio...ipment that,provides faster and more accurate trea...p://www.newscom.com/cgi-bin/prnh/20061117/DAF023LO...
(Date:7/18/2008)...the University of Pennsylvania School of Medicine ...ed with familial Alzheimer,s disease disrupt the f...ns, called PS1 and PS2 (presenilin 1 and 2), inter...ular cell compartment. , "The ,calcium dysregula...al Alzheimer,s disease has been suggested by previ...
(Date:7/18/2008)...istance to chemotherapy drugs, sometimes abruptly,...ing well to reduce tumors or hold them in check? ...lt when this occurs is all too familiar: patients ...ecome resistant. , A team of researchers at Cold...stand the genetic underpinnings of cancer therapy ...
(Date:7/18/2008)...wswire-USNewswire/ -- William S.,Harris, Ph.D., FA...ter,dated July 16:, Eating fish, especially oily...heart disease prevention. Fish is low in total and...ce minerals, and contains,long-chain omega-3 fatty...thy omega-3s include salmon, trout, albacore tuna,...
Breaking Medicine News(10 mins):Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 2Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 4Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 5Health News:Calcium may be the key to understanding Alzheimer's disease 2Health News:Calcium may be the key to understanding Alzheimer's disease 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 2Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 3
...s who are training for marathon running events may...ia (EAH) that can develop from low levels of sodiu...ened when the athletes drink excess amounts of flu... is increasing, but athletes, coaches, and medical...
...ving 3,189 school children from Denmark, Estonia a...ilies don’t necessarily have worse health compared...ucated parents. The results of the study were publ...the study challenge the results of the earlier rep...
...ear of marriage a wife may be able to control how ...abuse like the use of marijuana. However the rever...ollected showed that in the first year of marriage... likely to start or resume smoking marijuana if th...
...nning a pregnancy take a general multivitamin supp...t thing for them and their baby, however a recent ...development defects in unborn babies but many wome...multivitamin supplements say researchers based on ...
Other Medicine News:Health News:Athletes Warned Of Exercise-Associated Hyponatremia 2Health News:Wife May Determine Husband’s Marijuana Use 2
(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCSD...-- Raptor,Pharmaceuticals Corp. ("Raptor" or the "...ced the execution of a collaboration agreement (th...San Diego ("UCSD") to,include a Phase 2a clinical ... cysteamine bitartrate ("Cysteamine") in adolescen...
(Date:7/15/2008)... Fund Completion of Phase III Trials of Light Infu...tatic Colorectal Cancer and Phase I/II a... BELLEVUE, Wash., July 15 /- Light S...pany developing Light Infusion Therapy(TM),(Litx(T...nounced that it,has raised $40.1 million in a Seri...
(Date:7/15/2008)...Reports 92 Percent Response Rate to Combination Tr...ll/ -- Cephalon, Inc. (Nasdaq:,CEPH) announced tod...in the,Journal of Clinical Oncology, 92 percent of... cell non-Hodgkin,s lymphoma (NHL) responded to tr...e) for Injection plus rituximab.,This combination ...
(Date:7/14/2008)... VIEW, Calif., July 14 /- M...nounced it has initiated its,Phase 3 clinical prog...or,migraine., MAP0004 is orally inhaled and self-...oprietary Tempo(R) inhaler. In the company,s prior...ief in as fast as 10 minutes,with relief sustaine...
Breaking Medicine Technology:Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 3Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 4Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 5MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 1Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 1AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9FindCareHomes com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home Care 11484 1FindCareHomes com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home Care 11484 2
...ne 4, 2007 – Data presented,today at this ye...ASCO) meeting in Chicago show that a novel combina...uorouracil (5-FU) therapy UFT,(tegafur–uraci...ponse rate in the first-line treatment of metastat...(Study of CPT-11 with Oxaliplatin combined,with UF...
...ne 4, 2007 – Genta,Incorporated (Nasdaq: GNT...ase 2 clinical trial of its marketed product, Gani...b (Rituxan®;,Genentech/IDEC) and dexamethasone...in’s lymphoma (NHL). The data were,presented...Clinical,Oncology (ASCO) in Chicago, IL. , ,Previo...
Other Medicine Technology:Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 2Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
Micro Decker Pituitary Rongeurs, 6 length 150 mm, heavy duty.
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery.
It is designed for rigid skeletal fixation, and allows the surgeon greater freedom in positioning the fixation pins. The 3-point rigid skeletal fixation is designed for the supine, prone, lateral, or
...rl Storz borescopes are rigid endoscopes for gener...opkins lens system. The diameters of borescopes, i..., with viewing directions from 0 up to a 120 retro...lens and wide angle view. Endoscopes with working ...
Medicine Products: